Adult(s) with frequent use of acute migraine medications that also received prophylactic medications.

See attached "Migraine ebm Alg" document for member demographics, member enrollment, and condition confirmation criteria for denominator migraine definition. In addition, for this measure, the patient must be 18 years of age or older at the end of the report period and must meet the following criteria:
Identify patients with frequent headache, as defined in Appendix 1
Are any of the following equal to YES: 1,2,3,4,5,6,7

1: Was the sum of the Equivalent Doses (EqDose) for triptan (oral only) (code set RX-122) greater than a Threshold of 36 tablets, during the following time period: last 120 days of the report period? EqDose is a defined determination function. Note: Exclude the last claim within this time period. 
2: Was the sum of the Equivalent Doses (EqDose) for triptan (subcutaneous only) (code set RX-123) greater than a Threshold of 12 dose equivalents, during the following time period: last 120 days of the report period? Note: Exclude the last claim within this time period.
3: Was the sum of the Equivalent Doses (EqDose) for triptan (nasal only) (code set RX-121) greater than a Threshold of 24 spray bottles, during the following time period: last 120 days of the report period? Note: Exclude the last claim within this time period.
4: Was the sum of the Equivalent Doses (EqDose) for Butorphanol Tartrate (nasal only) (code set RX-29) greater than a Threshold of 10 ml, during the following time period: last 120 days of the report period? Note: Exclude the last claim within this time period.
5: During the following time period: last 120 days of the report period
Was the sum of the Equivalent Doses (EqDose) for Dihydroergotamine Mesylate (nasal only) (code set RX-42) greater than a Threshold of 12 ml? 
OR
Was the sum of the Equivalent Doses (EqDose) for dihydroergotamine mesylate (injection only) (code set RX-174) greater than a Threshold of 25 ml? Calculate EqDose for pharmacy claims.
6: Was the sum of the Equivalent Doses (EqDose) for butalbital containing medication (code set RX-28) greater than a Threshold of 100 tablets/capsules, during the following time period: last 120 days of the report period? Note: Exclude the last claim within this time period.
7: Was the sum of the Equivalent Doses (EqDose) for midrin type medication (code set RX-76) greater than a Threshold of 150 capsules, during the following time period: last 120 days of the report period? Note: Exclude the last claim within this time period.

Time Window: 120 days prior to the end of the report period for identification of frequent medication use (Note: migraine condition confirmation requires a time period of up to 24 months or use of a disease registry)